Sources: Amazon acquired PillPack in a deal valued at just under $1B; PillPack had been in acquisition talks with Walmart, which was outbid by Amazon
A week after appointing a CEO for its healthcare joint venture with Berkshire Hathaway and JPMorgan, Amazon today announced an acquisition …
Context & Ripple Effects
PillPack's arc runs from venture-backed challenger to strategic asset: the startup raised $50M in 2015 explicitly to take on Walgreens, and by acquisition time had pulled in $117.8M while holding pharmacy licenses in all 50 states. The deal came just a week after Amazon named a CEO for its healthcare joint venture with Berkshire Hathaway and JPMorgan, signaling that Amazon's healthcare push was moving from planning to execution on two fronts at once.
The competitive wrinkle is Walmart: sources say PillPack had been in talks with Walmart before Amazon outbid it, and Walmart would go on to build its own online-pharmacy answer in CareZone. The $500B-a-year prescription market Amazon is entering is also where CVS and Walgreens sit, per the related deep-dive into the deal.
First-order effects
- Amazon gains a licensed-in-50-states mail-order pharmacy overnight, skipping the years-long state-by-state licensing grind, while Walmart loses the target it was negotiating to buy.
Second-order effects
- Walmart is pushed to build rather than buy, fielding CareZone as its competing online pharmacy; UnitedHealth's later purchase of DivvyDose, which competed with both PillPack and CareZone, shows insurers moving to own the same delivery layer rather than cede it to retailers.
Third-order effects
- The pattern — Amazon buying PillPack for under $1B, then paying roughly four times that for primary-care provider One Medical in 2022 — points to retail-tech consolidating drug distribution and care delivery, forcing incumbents like CVS and Walgreens to compete on logistics and integration rather than storefronts.
The trend: Amazon is assembling a vertically integrated healthcare stack through acquisition, with each deal pulling pharmacy and primary care further away from traditional retail chains and insurers.